article thumbnail

The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association

Circulation

Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. This review highlights the important background, anatomic considerations, therapeutic options, and future directions with regard to treatment of tricuspid valve disease. Circulation, Ahead of Print.

article thumbnail

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker

DAIC

Tricuspid regurgitation (TR) is a common and serious disease for which open heart surgery and symptomatic pharmacologic treatment are the current standard treatment options. Importantly, the performance of the pacemaker was not affected by the valve.

article thumbnail

Case Report: Leadless and left bundle branch area pacemakers, complementary advantages require a personalized approach

Frontiers in Cardiovascular Medicine

Traditional transvenous pacemakers consist of a pacemaker generator usually positioned surgically in the upper left chest on the pectoral muscle fascia and one or more leads positioned through the veins to the right atrium and across the tricuspid valve to the right ventricular apex.

article thumbnail

Early experience with a novel transapical transcatheter aortic valve system in patients with severe aortic stenosis: a prospective, multicenter study

Frontiers in Cardiovascular Medicine

At 30-day follow-up, all-cause mortality, the incidence of major adverse cardiovascular events, major vascular complications, and new permanent pacemaker implantation were 3.8%, 4.6%, 0.8%, and 0.8%, respectively. of patients showedmild paravalvular leakage, and all 125 (100%) patients were in New York Heart Association ClassII.

article thumbnail

Low prevalence of new-onset severe tricuspid regurgitation following leadless pacemaker implantation in a large series of consecutive patients

HeartRhythm

Tricuspid regurgitation (TR) is a well-known complication after transvenous pacemaker implantation that is less well described for leadless pacemakers (LPs).1 1 Previous studies have reported discordant data regarding the incidence of significant TR with LP compared to transvenous systems.24

article thumbnail

PO-03-174 PREDICTORS OF PERMANENT PACEMAKER PLACEMENT IN PATIENTS UNDERGOING TRICUSPID VALVE SURGERY-A RETROSPECTIVE COHORT STUDY OF THE NATIONAL INPATIENT SAMPLE

HeartRhythm

Tricuspid valve surgery for isolated tricuspid valve disease is becoming increasingly common. These patients often need permanent pacemaker (PPM) post-surgery. Incidence and risk factors of this complication are not well established.

article thumbnail

PO-02-187 EFFECT OF PACEMAKER LEAD SIZE ON DEGREE OF TRICUSPID REGURGITATION: A FOCUS ON THE MEDTRONIC MODEL 3830 LEAD

HeartRhythm

Tricuspid regurgitation (TR) is a common valvular disorder with a spectrum of etiologies including mechanical disturbance of the tricuspid valve by catheters, wires, and the presence of a pacemaker or defibrillator.